Finger Plethysmography to Predict Fluid Responsiveness in Healthy Pregnancy and Severe Preeclampsia
Part of paid clinical trials in Palo Alto, California.
- Sponsor
- Stanford University
- Study ID
- NCT07430254
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Pre-Eclampsia, Severe
- Pregnancy
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Noninvasive finger plethysmographic cardiac output monitoring — DIAGNOSTIC_TESTNoninvasive hemodynamic monitoring used to assess changes in cardiac output for prediction of fluid responsiveneness
- Standard transthoracic echocardiographic assessment — DIAGNOSTIC_TESTNoninvasive hemodynamic monitoring (echocardiography) used to assess changes in cardiac output for prediction of fluid responsiveness
Study Details
The goal of this observational study is to determine whether noninvasive finger plethysmographic cardiac output monitoring can help predict fluid responsiveness in pregnant women, including those with preeclampsia with severe features. The main questions it aims to answer are : * Can changes in cardiac output measured by finger plethysmography predict fluid responsiveness? * How does this method perform compared with standard echocardiographic assessment? Participants will provide consent and undergo noninvasive hemodynamic monitoring and a brief reversible physiological challenge.
Key Dates
- Start date
- Jul 1, 2026
- Status verified
- Feb 2026
- Primary completion
- Jul 1, 2028
- Completion
- Jul 1, 2028
Study Design
- Enrollment
- 88 participants (estimated)
Arms
- Arm: Healthy pregnant womenPregnant participants without hypertensive disorders enrolled for brief, noninvasive hemodynamic assessments
- Arm: Preeclampsia With Severe FeaturesWomen diagnosed with preeclampsia with severe features enrolled for brief, noninvasive hemodynamic assessments
Primary Outcome Measure
Prediction Accuracy for Change in Cardiac Output for Fluid Responsiveness [ Time Frame: Baseline (semi-recumbent) and 1 minute after passive leg raising ]
Central Contacts
- Study Team(650) 723-5403
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Lucile Packard Children's Hospital | Palo Alto | California | 94304 | - |
Find similar trials in Palo Alto, CA
Related Studies
- Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy ProjectRecruiting · University of California, San Diego · La Jolla, California
- UCLA Perinatal Biospecimen RepositoryRecruiting · Yalda Afshar, MD, PhD · Los Angeles, California
- Kesimpta (Ofatumumab) Pregnancy RegistryRecruiting · Novartis Pharmaceuticals · La Jolla, California
- Predicate and Lay User-HCP Comparison Study of a Multi-Level Urine hCG Pregnancy TestNot Yet Recruiting · Conceptra Biosciences, LLC · Los Angeles, California